Medipal HoldingsMAHLY 78 Dividend Yield % is 2.71% as of Jun. 25, 2026, which is 36% above its 10-year median of 1.99. GuruFocus rates MAHLY with a GF Score™ of 78/100 and a GF Value™ of $15.83 (Fairly Valued). The stock has 1 warning sign investors should review. Among 69 Medical Distribution companies, Medipal Holdings ranks worse than 57.97% on this metric.
As of today (2026-06-25), the Trailing Annual Dividend Yield of Medipal Holdings is 2.71%.
Good Sign:
Medipal Holdings Corp stock Dividend Yield % is close to 10-year high.
The historical rank and industry rank for Medipal Holdings's Dividend Yield % or its related term are showing as below:
MAHLY'
s Dividend Yield % Range Over the Past 10 Years
Min: 1.32 Med: 1.99 Max: 2.77
Current: 2.71
During the past 13 years, the highest Dividend Yield of Medipal Holdings was 2.77%. The lowest was 1.32%. And the median was 1.99%.
MAHLY's Dividend Yield % is ranked worse than 57.97% of 69
companies
in the Medical Distribution industry
Industry Median: 2.86
vs MAHLY: 2.71
During the past 12 months, Medipal Holdings's average Dividends Per Share Growth Rate was 6.50% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was 12.80% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was 10.70% per year.
During the past 10 years, the average Dividends Per Share Growth Rate was 8.70% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Medipal Holdings was 44.20% per year. The lowest was 0.00% per year. And the median was 10.10% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
The historical data trend for Medipal Holdings's Dividend Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MAHLY vs MCK, COR, CAH: Dividend Yield % Comparison
For the Medical Distribution subindustry, Medipal Holdings's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medipal Holdings Dividend Yield % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Medipal Holdings's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Medipal Holdings's Dividend Yield % falls into.
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Medipal Holdings Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
USD 0.212486
2026-03-31
2026-03-31
2026-06-16
Cash Dividend
semi-annually
USD:USD 1.000000
USD 0.204682
2025-09-30
2025-09-30
2025-12-16
Cash Dividend
semi-annually
USD:USD 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
Medipal Holdings's Trailing Annual Dividend Yield (%) for Today is calculated as
Medipal Holdings's Forward Annual Dividend Yield (%) for Today is calculated as
Forward Annual Dividend Yield
=
Forward Full Year Dividend
/
Current Share Price
=
0.424972
/
15.37
=
2.76 %
Current Share Price is $15.37. Medipal Holdings's Dividends per Share for the forward twelve months is calculated as $0.212486 * 2 = $0.424972.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medipal Holdings (MAHLY) has a Dividend Yield % of 2.71% as of Jun. 25, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on Medipal Holdings and its competitors. This is 36% above median its historical median of 1.99. Over the past decade, Medipal Holdings' Dividend Yield % has ranged from 1.32 to 2.77. According to the industry distribution chart, Medipal Holdings ranks #40 out of 69 companies in the Medical Distribution industry, placing it in the top 58%.
Is Medipal Holdings' Dividend Yield % too high?
Medipal Holdings' current Dividend Yield % of 2.71% is 36% above median its 10-year median of 1.99. Over the past 10 years, this metric has ranged from a low of 1.32 to a high of 2.77. The Medical Distribution industry median Dividend Yield % is 2.86. Medipal Holdings' value of 2.71% is 5.2% below this industry median. Based on the distribution chart, Medipal Holdings ranks #40 out of 69 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Medipal Holdings has a GF Score™ of 78/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Medipal Holdings' Dividend Yield % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Medipal Holdings ranks #40 out of 69 companies for Dividend Yield %. This places Medipal Holdings in the lower half of its industry. The industry median Dividend Yield % is 2.86. Medipal Holdings' value of 2.71% is 5.2% below this benchmark. Historically, Medipal Holdings' own Dividend Yield % has ranged from 1.32 to 2.77 over the past decade. While the company's 10-year median is 1.99 vs. the industry median of 2.86, Medipal Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Medical Distribution company?
The median Dividend Yield % among Medical Distribution companies is 2.86, based on 69 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medipal Holdings's current Dividend Yield % of 2.71% is 5.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on Medipal Holdings and its competitors. For the Medical Distribution industry, the median Dividend Yield % is 2.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medipal Holdings's current Dividend Yield % is 2.71%, which is 36% above median its own 10-year median of 1.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medipal Holdings stock overvalued right now?
Based on GuruFocus' analysis, Medipal Holdings (MAHLY) is currently considered Fairly Valued. The stock's GF Value™ is $15.83, compared to a current price of $15.37 — trading 2.9% below its estimated fair value. The current Dividend Yield % is 2.71%, which is 36% above median its 10-year median of 1.99 and 5.2% below the Medical Distribution industry median of 2.86. Medipal Holdings' overall GF Score™ is 78/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For Medipal Holdings (MAHLY), the current Dividend Yield % is 2.71% as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medipal Holdings (MAHLY) Overvalued in 2026?
Based on GuruFocus' analysis, Medipal Holdings stock appears to be undervalued.
The current stock price of $15.37 is trading 2.9% below its estimated GF Value™ of $15.83.
GuruFocus considers Medipal Holdings to be Fairly Valued.
Key valuation signals for MAHLY:
Dividend Yield %: 2.71% (36% above median its 10-year median of 1.99)
GF Value™: $15.83 vs. price of $15.37 (2.9% below fair value)
Industry Position: 5.2% below the Medical Distribution median (#40 of 69)
No single metric tells the full story. See the MAHLY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medipal Holdings Corp is engaged in the wholesale distribution of pharmaceuticals, cosmetics, daily necessities, and related products. The company operates through three reportable segments: Wholesale business of medical drugs; Cosmetics, Daily Necessities and OTC Pharmaceuticals Wholesale Business; and Wholesale of animal medicines and food processing ingredients. The Wholesale business of medical drugs segment targets hospitals, clinics, and dispensing pharmacies; the Cosmetics and OTC segment serves drug stores, home centers, convenience stores, and supermarkets; while the Wholesale of animal medicines and food processing ingredients segment supplies veterinary clinics, livestock and fisheries businesses, and food manufacturers.
78GF Score
Get the complete analysis for MAHLY
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MAHLY has been successfully added to your 
